Clinical Trial: An Open-label, Multicenter, Parallel-group Randomized Clinical Trial Assessing Non-inferiority of Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07843017) titled 'An Open-label, Multicenter, Parallel-group Randomized Clinical Trial Assessing Non-inferiority of Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia' on Sept. 21.

Brief Summary: This trial aims to determine whether treatment with inhaled levofloxacin (an antibiotic) is equal to systemic antibiotic treatment (usual care) for patients admitted to a hospital with community-acquired pneumonia in regards to treatment-effect and safety parameters.

Additionally, this study will assess if treatment with inhaled antibiotics leads to fewer antibiotic side-effects and a more preserved gastro-intestinal microbial...